Comment from lisa Johnson

We need total transparency in all things medical for the patient to view without it being hidden. The FDA should regulate Narxcare and be transparent about the information used to generate a “score” that determines patient care. Without knowing the collected and used information, we cannot assess its accuracy or dispute it if necessary.